{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T03:41:40Z","timestamp":1778384500347,"version":"3.51.4"},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA258540"],"award-info":[{"award-number":["R01CA258540"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP220051"],"award-info":[{"award-number":["RP220051"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance in Med"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      To investigate contrast\u2010enhanced\n                      <jats:styled-content style=\"fixed-case\">T1<\/jats:styled-content>\n                      \u2010weighted\n                      <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content>\n                      and diffusion\u2010weighted magnetic resonance imaging (\n                      <jats:styled-content style=\"fixed-case\">DWI<\/jats:styled-content>\n                      ) for early prediction of tumor response to combined irreversible electroporation (\n                      <jats:styled-content style=\"fixed-case\">IRE<\/jats:styled-content>\n                      ) and anti\u2010\n                      <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                      \u20101 immunotherapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Murine pancreatic ductal adenocarcinoma (\n                      <jats:styled-content style=\"fixed-case\">PDAC<\/jats:styled-content>\n                      ) cells\n                      <jats:styled-content style=\"fixed-case\">KRAS<\/jats:styled-content>\n                      * were inoculated into the pancreas of\n                      <jats:styled-content style=\"fixed-case\">C57BL<\/jats:styled-content>\n                      \/6 mice.\n                      <jats:styled-content style=\"fixed-case\">IRE<\/jats:styled-content>\n                      was performed when tumors became palpable. After\n                      <jats:styled-content style=\"fixed-case\">IRE<\/jats:styled-content>\n                      , mice received six intraperitoneal injections of anti\u2010\n                      <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                      \u20101 over 2\u2009weeks.\n                      <jats:styled-content style=\"fixed-case\">T2<\/jats:styled-content>\n                      \u2010weighted\n                      <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content>\n                      ,\n                      <jats:styled-content style=\"fixed-case\">T1<\/jats:styled-content>\n                      \u2010weighted\n                      <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content>\n                      with macromolecular contrast agent poly(L\u2010glutamic acid)\u2010conjugated gadolinium (\n                      <jats:styled-content style=\"fixed-case\">PG<\/jats:styled-content>\n                      \u2010Gd), and\n                      <jats:styled-content style=\"fixed-case\">DWI<\/jats:styled-content>\n                      were performed before and after\n                      <jats:styled-content style=\"fixed-case\">IRE<\/jats:styled-content>\n                      . Survival was analyzed using Kaplan\u2013Meier curves. Mice surviving at least 100\u2009days without recurrence after\n                      <jats:styled-content style=\"fixed-case\">IRE<\/jats:styled-content>\n                      were considered complete responders. Relationships between\n                      <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content>\n                      findings and treatment response were assessed with one\u2010way\n                      <jats:styled-content style=\"fixed-case\">ANOVA<\/jats:styled-content>\n                      , Student's\n                      <jats:italic>t<\/jats:italic>\n                      \u2010test, and receiver operating characteristic (\n                      <jats:styled-content style=\"fixed-case\">ROC<\/jats:styled-content>\n                      ) analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Tumor volume on\n                      <jats:styled-content style=\"fixed-case\">T2<\/jats:styled-content>\n                      \u2010weighted\n                      <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content>\n                      at early treatment time\u2010points did not correlate with survival.\n                      <jats:styled-content style=\"fixed-case\">T1<\/jats:styled-content>\n                      \u2010weighted\n                      <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content>\n                      with\n                      <jats:styled-content style=\"fixed-case\">PG<\/jats:styled-content>\n                      \u2010Gd clearly showed increased\n                      <jats:styled-content style=\"fixed-case\">PG<\/jats:styled-content>\n                      \u2010Gd uptake in tumors on days 4 and 11\u201314 after\n                      <jats:styled-content style=\"fixed-case\">IRE<\/jats:styled-content>\n                      and anti\u2010\n                      <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                      \u20101 immunotherapy. Higher\n                      <jats:styled-content style=\"fixed-case\">PG<\/jats:styled-content>\n                      \u2010Gd uptake correlated with longer survival (\n                      <jats:styled-content style=\"fixed-case\">\n                        R\n                        <jats:sup>2<\/jats:sup>\n                      <\/jats:styled-content>\n                      \u2009=\u20090.634;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Area\u2010under\u2010the\u2010\n                      <jats:styled-content style=\"fixed-case\">ROC<\/jats:styled-content>\n                      curve had high predictive value for treatment outcome (0.805;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.033). Immunofluorescence staining confirmed high accumulation of macrophages in tumors after treatment. On\n                      <jats:styled-content style=\"fixed-case\">DWI<\/jats:styled-content>\n                      , all\n                      <jats:styled-content style=\"fixed-case\">KRAS<\/jats:styled-content>\n                      * tumors exhibited significantly increased apparent diffusion coefficient (\n                      <jats:styled-content style=\"fixed-case\">ADC<\/jats:styled-content>\n                      ) values 7, 11, and 14\u2009days after combination therapy. Moreover, pretreatment tumor\n                      <jats:styled-content style=\"fixed-case\">ADC<\/jats:styled-content>\n                      values were significantly higher in complete responders than in partial responders (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0025).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">PG<\/jats:styled-content>\n                      \u2010Gd contrast\u2010enhanced\n                      <jats:styled-content style=\"fixed-case\">T1<\/jats:styled-content>\n                      \u2010weighted\n                      <jats:styled-content style=\"fixed-case\">MRI<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">DWI<\/jats:styled-content>\n                      are potential predictors of response to combined\n                      <jats:styled-content style=\"fixed-case\">IRE<\/jats:styled-content>\n                      and anti\u2010\n                      <jats:styled-content style=\"fixed-case\">PD<\/jats:styled-content>\n                      \u20101 immunotherapy in\n                      <jats:styled-content style=\"fixed-case\">PDAC<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/mrm.70188","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:35:41Z","timestamp":1763699741000},"page":"2266-2276","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multiparametric\n                    <scp>MRI<\/scp>\n                    to Predict Response to Irreversible Electroporation Plus Anti\u2010\n                    <scp>PD<\/scp>\n                    \u20101 Immunotherapy in Pancreatic Ductal Adenocarcinoma"],"prefix":"10.1002","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8523-3468","authenticated-orcid":false,"given":"Qizhen","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Cancer Systems Imaging The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8109-3995","authenticated-orcid":false,"given":"Mark D.","family":"Pagel","sequence":"additional","affiliation":[{"name":"Department of Cancer Systems Imaging The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles V.","family":"Kingsley","sequence":"additional","affiliation":[{"name":"Department of Imaging Physics The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingfei","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Imaging Physics The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Biostatistics The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Cancer Systems Imaging The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth T.","family":"Gammon","sequence":"additional","affiliation":[{"name":"Department of Cancer Systems Imaging The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Delacerda","sequence":"additional","affiliation":[{"name":"Department of Cancer Systems Imaging The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Javadi","sequence":"additional","affiliation":[{"name":"Department of Abdominal Imaging The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cancer Systems Imaging The University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00681-z"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0011"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-200401000-00023"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.02.008"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa6204"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08782-1"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14122876"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00260-1"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105240"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S331023"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2020.04.057"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.16.17207"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015150031"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.2019190031"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2017.10.036"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.01.011"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.01.058"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioelechem.2018.03.005"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11281"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.4103\/tjem.tjem_182_23"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181ec173d"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22986"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.10100645"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature22396"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0000000000000505"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.21411"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.18.20017"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.21340"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13010089"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI58832"}],"container-title":["Magnetic Resonance in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mrm.70188","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/mrm.70188","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mrm.70188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:07:31Z","timestamp":1770908851000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mrm.70188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1002\/mrm.70188"],"URL":"https:\/\/doi.org\/10.1002\/mrm.70188","archive":["Portico"],"relation":{},"ISSN":["0740-3194","1522-2594"],"issn-type":[{"value":"0740-3194","type":"print"},{"value":"1522-2594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"2025-09-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}